Ontology highlight
ABSTRACT:
SUBMITTER: Schafer S
PROVIDER: S-EPMC5807082 | biostudies-literature | 2017 Dec
REPOSITORIES: biostudies-literature
Schafer Sebastian S Viswanathan Sivakumar S Widjaja Anissa A AA Lim Wei-Wen WW Moreno-Moral Aida A DeLaughter Daniel M DM Ng Benjamin B Patone Giannino G Chow Kingsley K Khin Ester E Tan Jessie J Chothani Sonia P SP Ye Lei L Rackham Owen J L OJL Ko Nicole S J NSJ Sahib Norliza E NE Pua Chee Jian CJ Zhen Nicole T G NTG Xie Chen C Wang Mao M Maatz Henrike H Lim Shiqi S Saar Kathrin K Blachut Susanne S Petretto Enrico E Schmidt Sabine S Putoczki Tracy T Guimarães-Camboa Nuno N Wakimoto Hiroko H van Heesch Sebastiaan S Sigmundsson Kristmundur K Lim See L SL Soon Jia L JL Chao Victor T T VTT Chua Yeow L YL Tan Teing E TE Evans Sylvia M SM Loh Yee J YJ Jamal Muhammad H MH Ong Kim K KK Chua Kim C KC Ong Boon-Hean BH Chakaramakkil Mathew J MJ Seidman Jonathan G JG Seidman Christine E CE Hubner Norbert N Sin Kenny Y K KYK Cook Stuart A SA
Nature 20171113 7683
Fibrosis is a common pathology in cardiovascular disease. In the heart, fibrosis causes mechanical and electrical dysfunction and in the kidney, it predicts the onset of renal failure. Transforming growth factor β1 (TGFβ1) is the principal pro-fibrotic factor, but its inhibition is associated with side effects due to its pleiotropic roles. We hypothesized that downstream effectors of TGFβ1 in fibroblasts could be attractive therapeutic targets and lack upstream toxicity. Here we show, using inte ...[more]